Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation
IART
Valuace
70
Růst
23
Zdraví
67
Cena
$ 11.78
Dnes
--0.24 (-1.90%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.9B
Obrat
2B
Zisk
-1B
Aktiva
4B
Dluh
0B
ROE
-48%
ROA
-14%
PE
-1
PS
0
Cena 1R
11-27
⌀ Cena
13.74
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Společnost Integra LifeSciences Holdings Corporation vyvíjí, vyrábí a prodává chirurgické implantáty a lékařské nástroje pro použití v neurochirurgii, rekonstrukci končetin a všeobecnou chirurgii. Působí ve dvou segmentech, Codman Speciality Surgical a Tissue Technologies. Společnost nabízí neurochirurgické a neurochirurgické produkty a produkty pro kritickou péči, včetně zařízení pro ablaci tkání, produktů pro dvojité opravy, zařízení pro řízení mozkové spinální tekutiny, zařízení pro intrakraniální monitorování a zařízení pro stabilizaci lebky, chirurgických světlometů a přístrojů, jakož i software pro správu majetku a podporu a služby po uvedení na trh. Prodává také přibližně 40 000 přístrojů a chirurgických a osvětlovacích produktů nemocnicím a chirurgickým centrům, stejně jako stomatologickým, podiaturním a veterinárním úřadům. Kromě toho společnost poskytuje regenerativní technologické produkty pro léčbu akutních a chronických ran a přípravky pro chirurgickou opravu tkání pro opravu kýly, opravu a ochranu periferních nervů a opravu šlach. Dále nabízí kožní a poranění, plasty a chirurgické rekonstrukční produkty, kostní štěpy a výrobky pro opravy nervů a šlach. Společnost nabízí své produkty přímo prostřednictvím různých prodejních sil a jiných distribučních kanálů nemocnicím, integrovaným zdravotnickým sítím, skupinovým nákupním organizacím, klinickým lékařům, chirurgickým centrům a poskytovatelům zdravotní péče ve Spojených státech, Evropě, Asii a Tichomoří a mezinárodně. Společnost Integra LifeSciences Holdings Corporation byla založena v roce 1989 a sídlí v Princetonu v New Jersey.
Sektor
Healthcare
Odvětví
Medical - Devices
Počet zaměstnanců
4396
Založení
1995-08-16
Adresa
1100 Campus Road
CEO
Mojdeh Poul

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues1,635.21,635.21,610.51,541.61,557.71,542.41,371.91,517.61,472.41,188.2992.1882.7928.3836.2830.9780.1732.1
Cost of Revenues790.0790.0728.5653.2587.4597.8520.8564.7571.5435.5349.1326.5352.8334.1314.4299.2268.2
Gross Profit845.2845.2882.1888.4970.3944.6851.0952.9900.9752.7643.0556.2575.5502.1516.4480.9463.9
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues434.9402.1415.6382.7442.6380.8418.2368.9397.0382.4
Cost of Revenues219.6176.0206.3188.2193.6180.6192.3162.0163.1164.1
Gross Profit215.4226.1209.3194.4249.1200.2225.9206.8234.0218.3
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0174.6101.293.177.479.678.063.558.250.951.652.151.051.548.1
Selling General & Admin Expenses0.00.00.0592.6616.3637.4594.5687.6690.7624.1455.6415.8446.0394.3373.1358.1305.1
Depreciation & Amortization151.0151.0140.5123.537.843.041.527.021.220.413.910.012.447.018.516.439.2
Total Operating Expenses776.9776.9853.7836.4731.4747.4699.7794.2789.9707.9527.6476.6510.0459.0442.7426.0365.2
Operating Income68.368.328.4111.5238.9197.2151.4179.0111.044.8115.379.665.5-3.673.854.998.7
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.024.326.6
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0147.4161.9
Depreciation & Amortization38.038.237.737.237.536.036.830.630.530.6
Total Operating Expenses-340.8185.8722.0209.9213.4208.4228.9202.9178.1191.8
Operating Income556.240.3-512.7-15.535.6-8.2-3.04.055.926.6
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income15.818.520.017.211.96.79.310.82.80.30.00.00.20.41.20.50.2
Interest Expense87.786.370.651.449.650.471.654.064.735.025.823.522.019.822.227.618.4
Other Expense-631.8-631.8-46.6-30.5-25.017.4-57.9-118.98.31.30.84.6-0.8-48.5-0.70.81.6
IBT-563.5-563.5-18.281.1213.9214.793.560.157.411.490.460.743.0-24.852.028.582.1
Income Tax Expense-47.0-47.0-11.313.333.345.6-40.49.9-3.4-53.415.853.89.0-7.810.80.516.4
Net Income-516.5-516.5-6.967.7180.6169.1133.950.260.864.774.6-3.534.0-17.041.228.065.7
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income4.45.04.71.84.95.05.15.02.74.6
Interest Expense23.722.721.020.219.019.418.713.618.913.1
Other Expense-551.9-47.1-18.3-14.5-13.1-12.2-12.2-9.2-7.2-8.0
IBT4.3-6.8-531.0-30.022.5-20.4-15.2-5.228.918.6
Income Tax Expense6.0-1.4-46.9-4.73.1-9.7-2.8-1.99.0-0.9
Net Income-1.7-5.4-484.1-25.319.4-10.7-12.4-3.319.819.5
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$0.87$2.18$2.00$1.59$0.59$0.72$0.83$1.00$-0.05$0.52$-0.30$0.74$0.52$1.11
EPS Diluted$0.00$0.00$0.00$0.84$2.16$1.98$1.57$0.58$0.72$0.82$0.94$-0.05$0.52$-0.29$0.72$0.48$1.09
Shares Outstanding76.876.877.078.283.084.784.385.684.478.474.773.965.556.855.953.759.1
Diluted Shares Outstanding76.876.877.080.383.585.585.286.584.479.179.273.965.957.657.059.060.3
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.25$0.24
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.25$0.24
Shares Outstanding76.876.876.576.577.076.477.477.778.379.7
Diluted Shares Outstanding76.876.876.576.577.076.477.477.778.379.8
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents215.2246.4276.4456.7513.4470.2198.9138.8174.9102.148.172.0120.696.9100.8128.8
Short Term Investments81.727.232.70.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments296.9273.6309.1456.7513.4470.2198.9138.8174.9102.148.172.0120.696.9100.8128.8
Accounts Receivable277.8272.4259.3263.5231.8225.5275.3265.7251.8148.2132.2131.9118.1114.9118.1106.0
Inventory421.8429.1389.6324.6317.4310.1316.1280.3296.3217.3211.4237.1213.4171.8171.3146.9
Other Current Assets115.8106.7100.0116.891.1231.467.990.299.127.742.629.626.830.362.163.2
Total Current Assets1,112.31,081.71,058.01,161.51,153.71,237.2858.2775.1822.1495.2438.5529.3525.2453.1452.3444.8
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents232.2217.9239.1246.4215.2215.2591.9276.4273.7309.2
Short Term Investments35.735.734.227.262.481.771.232.719.920.2
Total Cash & ST Investments267.9253.6273.3273.6277.6296.9663.1309.1273.7309.2
Accounts Receivable262.2284.5252.4272.4248.3277.8241.1259.3256.3258.7
Inventory489.1465.1445.4429.1436.9421.8403.4389.6366.3354.3
Other Current Assets124.4139.6136.1106.7136.7115.8108.0100.0131.0129.1
Total Current Assets1,143.61,142.81,107.21,081.71,099.51,112.31,415.71,058.01,027.21,051.3
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment521.0549.8496.4459.6396.2371.2431.9300.1269.3222.4205.2210.0200.3177.9131.499.5
Goodwill1,104.61,097.01,055.51,038.91,013.5932.4954.3926.5937.9510.6512.4363.9249.8294.1293.0261.9
Intangible Assets1,219.91,207.61,067.81,126.61,145.6989.41,031.61,079.51,159.6561.2603.7459.5197.2212.3237.1194.9
Long-Term Investments46.038.330.7567.30.00.00.00.00.00.00.00.00.00.00.00.0
Other Long-Term Assets24.828.227.5-510.216.411.314.619.916.111.78.010.48.310.413.18.3
Total Long-Term Assets2,962.22,955.72,724.02,728.32,628.72,377.92,445.12,332.82,389.11,312.81,336.21,049.3671.0710.5691.9572.5
Total Assets4,074.54,037.43,782.03,889.83,782.43,615.13,303.23,107.93,211.31,808.01,774.71,578.61,196.21,163.61,144.11,017.3
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment0.0571.4561.4549.8537.2521.0497.2496.4475.5466.2
Goodwill615.2616.41,105.41,097.01,116.51,104.61,040.21,055.51,036.11,043.3
Intangible Assets1,160.11,188.11,187.51,207.61,209.51,219.91,022.61,067.81,067.01,093.6
Long-Term Investments0.018.526.938.326.546.043.532.252.540.9
Other Long-Term Assets727.527.726.328.227.624.824.926.025.426.3
Total Long-Term Assets2,502.92,525.12,945.52,955.72,966.32,962.22,662.62,724.02,712.12,726.3
Total Assets3,646.53,667.94,052.84,037.44,065.84,074.54,078.23,782.03,739.43,777.6
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable107.582.592.3102.161.854.6113.176.194.029.134.834.150.836.727.727.8
Short-Term Debt38.8621.629.852.759.8159.157.322.560.00.014.43.80.00.00.0108.4
Other Current Liabilities172.1207.5176.3158.8213.1182.1156.2160.2183.987.7168.6166.164.466.769.7118.7
Current Liabilities328.3922.1307.0320.9340.0401.0331.3262.6348.9123.6139.1126.0119.4106.9101.9200.0
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.092.891.382.577.7107.594.492.393.699.8
Short-Term Debt52.6627.6626.8621.6616.538.835.729.8100.5110.3
Other Current Liabilities311.5198.3189.8207.5208.4172.1164.5176.3161.7159.2
Current Liabilities364.1929.8918.5922.1912.6328.3302.4307.0355.7377.5
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt1,801.11,362.91,651.91,562.61,591.51,496.31,400.61,331.71,781.1665.0700.6626.2392.1519.5532.3294.8
Capital Leases169.6181.5182.1172.0105.1100.9109.80.00.00.00.00.00.00.00.00.0
Def. Tax Liability86.560.835.363.345.816.236.657.865.1148.9154.991.62.15.45.710.6
Total Liabilities2,540.32,492.12,194.12,085.42,097.62,100.31,886.51,732.12,249.0968.31,023.3874.3526.0645.8651.5517.3
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt160.91,386.21,392.11,362.91,372.91,970.62,006.71,651.91,587.61,493.0
Capital Leases174.8173.4175.6181.5182.8169.6186.4166.8182.5174.2
Def. Tax Liability58.360.157.660.868.986.531.435.374.570.7
Total Liabilities2,608.92,629.22,528.62,492.12,544.22,540.32,480.32,194.12,160.22,094.4
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.90.90.90.90.90.90.90.90.80.80.50.40.40.40.40.4
Retained Earnings931.2939.9946.9879.1698.6532.3398.6348.4285.2220.4145.9315.0285.0302.0260.8232.8
Comprehensive Income-18.7-27.6-15.110.3-45.2-74.1-76.4-45.4-23.8-57.2-47.9-23.50.9-4.8-9.1-1.8
Total Common Equity1,534.21,545.31,587.91,804.41,684.81,514.91,416.71,375.8962.3839.7751.4704.3670.2517.8492.6500.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.90.90.90.90.90.90.90.90.90.9
Retained Earnings425.1430.5914.6939.9920.5931.2943.6946.9927.0907.5
Comprehensive Income-32.0-30.9-24.1-27.6-24.9-18.7-10.6-15.11.74.8
Total Common Equity1,037.61,038.71,524.11,545.31,521.61,534.21,598.01,587.91,579.21,683.2
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt2,009.51,984.61,681.71,615.41,651.31,655.41,457.81,354.21,841.1665.0715.0630.0392.1519.5532.3403.3
Book Value1,534.21,545.31,587.91,804.41,684.81,514.91,416.71,375.8962.3839.7751.4704.3670.2517.8492.6500.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value1,037.61,038.71,524.11,545.31,521.61,534.21,598.01,587.91,579.21,683.2
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income23.6-516.5-6.967.7180.6169.1133.950.260.864.774.66.934.0-17.041.228.065.7
Depreciation & Amortization128.40.0140.9123.5118.3119.8116.0109.5110.788.972.758.961.147.052.650.239.2
Stock-Based Compensation24.10.024.420.127.736.219.621.320.821.617.315.515.110.49.126.817.2
Change Working Capital-46.4-33.7-31.0-81.6-39.418.2-41.3-14.51.7-1.3-11.2-16.9-39.3-33.9-24.0-15.1-19.0
Change In Accounts Receivable9.9-0.57.44.6-33.97.352.1-9.4-17.0-89.7-17.5-16.2-16.1-2.93.8-1.9-3.8
Change In Accounts Payable-8.526.7-2.7-20.217.332.9-57.514.73.695.3-0.41.62.49.9-21.1-11.86.7
Change In Inventories-49.5-46.8-28.1-59.8-29.15.4-48.3-43.38.30.1-9.6-3.8-27.0-42.0-0.71.7-7.4
Other Non-cash Items93.8600.622.822.0-18.1-28.139.8226.313.87.9-30.430.69.557.5-21.713.3-1.6
Cash from Operations141.70.00.0140.0264.5312.4203.8373.7199.7114.5116.494.579.553.358.7104.3105.6
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income0.0-5.4-484.1-25.319.4-10.7-12.4-3.319.819.5
Depreciation & Amortization0.038.537.737.237.636.036.830.630.530.6
Stock-Based Compensation0.05.65.31.97.24.47.25.65.85.5
Change Working Capital-15.324.3-18.0-24.7-12.022.40.9-23.410.1-34.1
Change In Accounts Receivable-16.522.5-28.021.5-31.528.8-6.716.8-0.50.2
Change In Accounts Payable23.05.815.9-18.0-5.46.815.1-19.21.9-6.2
Change In Inventories-3.3-23.3-6.4-13.7-0.6-10.31.7-19.0-16.4-15.8
Other Non-cash Items29.0-13.4512.91.55.5-20.59.79.17.44.1
Cash from Operations0.00.00.00.00.00.00.00.058.826.8
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-82.80.0-104.4-66.9-47.1-48.1-63.9-134.5-77.7-43.5-47.3-33.4-42.4-47.9-69.0-38.4-37.1
Acquisitions-282.00.0-277.80.0-27.5-113.40.0-30.526.7-1,195.60.2-328.9-320.9-3.0-7.3-152.0-5.2
Investments-81.70.0-49.0-32.70.00.0-7.8-207.00.00.30.00.00.00.0-67.90.00.0
Sales of Investment0.00.054.55.40.00.00.01.60.017.00.00.00.00.064.90.00.0
Other Investing Activities-76.30.00.00.016.10.13.765.71.30.54.5-9.70.00.50.00.00.0
Cash from Investing-441.10.00.0-94.2-58.6-161.4-68.1-304.7-49.7-1,221.3-42.6-372.0-363.3-50.3-79.3-190.4-42.3
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-49.1-15.2-20.1-28.9-29.6-29.6-29.7-15.5-24.5-13.1
Acquisitions0.00.00.00.04.20.0-282.00.00.00.0
Investments-8.5-0.4-1.5-7.0-4.10.0-10.5-38.5-32.70.0
Sales of Investment0.00.00.00.035.319.30.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.0-32.75.4
Cash from Investing0.00.00.00.00.00.00.00.0-57.2-7.7
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-450.70.00.054.5-148.6-125.5-545.2-246.1-660.0-117.0-696.2-468.9-195.6-165.0-147.2-256.3-88.2
Debt Issued857.01,984.6302.9120.8112.6121.4742.8349.7173.11,293.1646.2553.8433.537.5134.5385.3491.5
Issuance of Common Stock7.30.00.00.00.00.044.60.0349.60.00.0219.70.0152.50.028.50.0
Repurchase of Common Stock-178.4-0.2-52.5-275.0-125.00.0-100.00.00.00.00.00.00.00.00.0-83.5-31.3
Dividends Paid0.00.00.00.00.00.0-44.60.00.00.00.00.00.00.00.0-378.70.0
Other Financing Activities116.00.00.0-9.421.627.3766.9310.6129.51,285.9681.1507.7438.431.6159.3750.2117.9
Cash from Financing208.40.00.0-229.9-252.0-98.2121.664.5-180.91,168.9-15.1258.5242.819.012.160.1-1.6
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-6.874.9
Debt Issued213.5-1,800.3-5.234.4-4.9-20.0-32.9360.7646.2-486.1
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock-0.20.0-0.20.0-2.5-0.2-50.00.0-0.3-125.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.20.4
Cash from Financing0.00.00.00.00.00.00.00.0-6.9-49.7
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-403.1-11.3-30.0-180.3-56.843.3271.360.1-36.172.953.9-23.9-48.623.7-3.9-28.056.9
Closing Cash Balance215.2235.0246.4276.4456.7513.4470.2198.9138.8174.9102.148.172.0120.696.9100.8128.8
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash2.914.3-21.2-7.331.2-0.1-376.7315.52.7-344.7
Closing Cash Balance235.0232.2217.9239.1246.4215.2215.2591.9276.4-35.5
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow58.9-31.125.073.1217.4264.3139.9239.2121.971.069.161.137.15.4-10.365.968.4
Real Free Cash Flow34.8-31.10.652.9189.7228.1120.4217.9101.249.551.845.622.0-5.0-19.439.151.2
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-37.325.8-11.2-40.211.2-7.210.70.334.213.7
Real Free Cash Flow-37.320.2-16.5-42.04.0-11.53.5-5.328.48.2
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-1.3-189.9179.3
P/S0.42.5390.6
P/B0.72.8113.4
P/FCF-9.1-102.6149.9
Market cap$0.9$2.2
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets5.9 %43.3 %0 %
Debt to Income-41.3 %-6324 %0 %
Debt to Free cash flow-282.2 %6.6 %0 %
Interest expense percentage128.3 %30.7 %11.2 %
Current ratio3.1 3.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-49.8 %3.8 %0 %
ROA-14.2 %2 %0 %
CapEx to Revenue5.7 %5 %6 %
RaD to Revenue0 %5.9 %0 %
ROEM371,984.8 193955.3

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin53.5 %61.5 %61.9 %
Operating margin-27.5 %7.2 %17.9 %
Net margin-30.1 %3.9 %13 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %1.5 %0 %
Dividend payout percentage0 %-291.7 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding76.8 mil 73.0 mil
Employee count4.4 tis 2.4 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader